These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5521334)

  • 1. Urease and deaminase activities of fecal bacteria in hepatic coma.
    Sabbaj J; Sutter VL; Finegold SM
    Antimicrob Agents Chemother (Bethesda); 1970; 10():181-5. PubMed ID: 5521334
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the action mechanism of lactulose in hepatic coma--clarification of colon urease activity using C-14 urea in rats].
    Bircher J; Gmünder U; Haemmerli UP; Müller-Duysing W; Bally G; Haemmerli G; Hoffmann K
    Strahlentherapie Sonderb; 1968; 67():330-6. PubMed ID: 5719130
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of action of lactulose in portal systemic encephalopathy: colonic bacterial urease activity and bacterial flora in rats.
    Bircher J; Haemmerli UP; Müller-Duysing W; Bally G; Haemmerli G; Hoffmann K
    Rev Eur Etud Clin Biol; 1970 Dec; 15(10):1096-100. PubMed ID: 5517889
    [No Abstract]   [Full Text] [Related]  

  • 4. Ammonia production in the human colon. Effects of cleansing, neomycin and acetohydroxamic acid.
    Wolpert E; Phillips SF; Summerskill WH
    N Engl J Med; 1970 Jul; 283(4):159-64. PubMed ID: 5424005
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral neomycin dosage schedules for suppression of ammonia production by bowel flora.
    Suh B; Stephens JL; Kunin CM
    Antimicrob Agents Chemother; 1979 Oct; 16(4):519-22. PubMed ID: 518082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
    Bircher J; Haemmerli UP; Scollo-Lavizzari G; Hoffmann K
    Am J Med; 1971 Aug; 51(2):148-59. PubMed ID: 5095524
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of three antibacterial drugs in lowering blood & stool ammonia production in hepatic encephalopathy.
    Alexander T; Thomas K; Cherian AM; Kanakasabapathy
    Indian J Med Res; 1992 Oct; 96():292-6. PubMed ID: 1459672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Letter: neomycin in hepatic coma].
    Müting D
    Dtsch Med Wochenschr; 1973 Sep; 98(38):1783. PubMed ID: 4200493
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition by acetohydroxamic acid of human mucosal and faecal urease-specific activity.
    Aoyagi T; Summerskill WH
    Lancet; 1966 Feb; 1(7432):296-7. PubMed ID: 4158898
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in ammonia production by faecal bacteria of patients with hepatic encephalopathy.
    O'Grady F
    Proc R Soc Med; 1966 Dec; 59(12):1246. PubMed ID: 5955211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
    Müting D
    Clin Ter; 1967 Aug; 42(4):289-97. PubMed ID: 5608820
    [No Abstract]   [Full Text] [Related]  

  • 12. Deafness following oral use of neomycin.
    Kalbian VV
    South Med J; 1972 Apr; 65(4):499-501. PubMed ID: 5028411
    [No Abstract]   [Full Text] [Related]  

  • 13. Intestinal lactase deficiency and saccharide malabsorption during oral neomycin administration.
    Paes IC; Searl P; Rubert MW; Faloon WW
    Gastroenterology; 1967 Jul; 53(1):49-58. PubMed ID: 6027231
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypokalemia-induced hepatic coma in cirrhosis. Occurrence despite neomycin therapy.
    Artz SA; Paes IC; Faloon WW
    Gastroenterology; 1966 Dec; 51(6):1046-53. PubMed ID: 5958605
    [No Abstract]   [Full Text] [Related]  

  • 15. In hepatic coma, the problem comes from the colon, but will the answers come from there?
    Schafer DF
    J Lab Clin Med; 1987 Sep; 110(3):253-4. PubMed ID: 3611947
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of oral neomycin and kanamycin in chronic uremic patients: II. Nitrogen balance.
    Mitch WE; Walser M
    Kidney Int; 1977 Feb; 11(2):123-7. PubMed ID: 846063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficacy of neomycin and ampicillin against urease producing organisms.
    Koshy A; Ayyagari A; Bharati G; Goyal AK; Kaur U
    Indian J Med Res; 1981 Sep; 74():486-8. PubMed ID: 6915002
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic effects of oral neomycin.
    Asatoor AM; Chamberlain MJ; Emmerson BT; Johnson JR; Levi AJ; Milne MD
    Clin Sci; 1967 Aug; 33(1):111-24. PubMed ID: 6059291
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid.
    Summerskill WH; Thorsell F; Feinberg JH; Aldrete JS
    Gastroenterology; 1968 Jan; 54(1):20-6. PubMed ID: 5635434
    [No Abstract]   [Full Text] [Related]  

  • 20. Elimination of bacteria from dogs with antibiotics.
    Hayes NR; van der Waaij D; Cohen BJ
    J Hyg (Lond); 1974 Oct; 73(2):205-12. PubMed ID: 4529233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.